Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Health-related Quality of Life During Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Tumours

NCT05427032 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.

NCT NCT05427032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05427032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Health-related Quality of Life During Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Tumours
Lead sponsor
Uppsala University
Phase
Observational
Overall status
Completed
Start date
January 10, 2009
Completion date
December 10, 2018
Enrollment
756 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors, peptide receptor radionuclide therapy, quality of life